Buy 2,990 Shares of This Stock for $165.25/Month in Passive Income

A high-yield dividend stock can transform your investment into monthly passive income streams.

| More on:
profit rises over time

Source: Getty Images

Price swings or fluctuations are a universal risk in the stock market; no stock, regardless of sector, is insulated from headwinds. In Canada, dividend stocks are back in investors’ favour mainly due to the Bank of Canada’s rate-cutting cycle.

The Canadian Imperial Bank of Commerce said in August 2024 that money is plowing back into TSX dividend payers after the rate cuts in June and July. As of November 1, 2024, the central bank’s policy rate is down to 3.75% following a 25-basis points cut in September and a jumbo 0.50% reduction in October.

If you’re building a passive income portfolio or adding another income stock to your holdings, Chemtrade Logistics Income Fund (TSX:CHE.UN) is a sound choice. Besides a high yield, the stock pays monthly dividends. At $10.93 per share, the dividend offer is 6.04%. Also, current investors enjoy a 36.1% year-to-date gain on top of the generous payout.

If you buy 2,990 shares, the $32,830.20 investment will transform into $165.25 in monthly passive income. See the table below based on the given example:

CompanyRecent PriceNo. of Shares Div/ShareTotal PayoutFrequency
Chemtrade$10.982,990$0.6632$1,982.97*Monthly

                         *Total annual dividend payment; divide by 12 to get $165.25 monthly

Assuming you invest today and reinvest the monthly dividends, and do not pocket them, your capital will grow to $44,371.20 in five years due to the power of compounding. Your monthly dividends will become $223.34 after November 2029. The potential to earn higher monthly cash flow streams is ever-present if you can accumulate more shares.

Strong market position

Chemtrade is a $1.3 billion chemical manufacturer serving major industrial and consumer markets across North America and select countries. This diversified enterprise derives revenues from two core business segments. Investments in organic growth projects are ongoing to supplement growth. The 2024 growth capital budget is $60 million to $90 million.  

The Sulphur and Water Chemicals (SWC) segment manufactures and markets sulphur-based products and services, water treatment chemicals, and specialty chemicals. Chemtrade’s Electrochemicals (EC) manufactures and markets sodium chlorate and chlor-alkali products, for which its electrochemicals plant in Brazil has a long-term contract.

Financial performance

Chemtrade recorded record Adjusted EBITDA in 2022 and 2023 amid an inflationary environment and high interest rates. Management aims to achieve another record, although it might be a tall order due to maintenance turnaround, significantly lower selling prices in the EC segment, and reduced profit in SWC.

In the first half of 2024, revenue and Adjusted EBITDA declined 8% and 18.4% year-over-year to $866.3 million and $225 million, respectively. Nonetheless, if Chemtrade hits the high end of its EBITDA guidance range in 2024, it would result in its three highest ever years for Adjusted EBITDA. The company anticipates the second half to be stronger than the first six months.

Distribution track record

Long-time Chemtrade investors can attest to the stock’s reliability as a passive income provider. While the yield varies depending on market conditions, the monthly payouts have been uninterrupted since August 2001. Management assures that the dividends are safe and sustainable (57.3% payout ratio) because of the defensive nature of the key products.    

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.xxs

More on Dividend Stocks

concept of real estate evaluation
Dividend Stocks

The Smartest Real Estate Stocks to Buy With $1,000 Right Now 

The real estate market is a ripe investment opportunity. You can invest $1,000 in these REITs and benefit from property…

Read more »

Person holds banknotes of Canadian dollars
Dividend Stocks

The Smartest Dividend Stocks to Buy With $1,000 Right Now 

Did you receive $1,000 in holiday gifts? You could invest this money in these dividend stocks and give yourself small…

Read more »

Man data analyze
Dividend Stocks

Passive Income: How Much Do You Need to Invest to Make $500 Per Month?

Are you wondering how much cash you would need to earn $500 per month in passive income? Here are some…

Read more »

shopper chooses vegetables at grocery store
Dividend Stocks

Is Slate Grocery REIT a Buy Now?

If you're looking for consistent passive income that lasts, Slate Grocery REIT looks like a strong option. But there are…

Read more »

ETF stands for Exchange Traded Fund
Dividend Stocks

Strategies for Investing in Canadian Stocks After a Robust 2024

Want to invest in stocks but worried about overvaluation or volatility? These ETFs could be ideal.

Read more »

TFSA (Tax free savings account) acronym on wooden cubes on the background of stacks of coins
Dividend Stocks

How to Use Your TFSA to Earn $254 Per Month in Tax-Free Income

These stocks offer high yields near the current levels, making them compelling investments to generate tax-free income.

Read more »

AI-Impact-On-Investment-Economy-ETFs-2024
Dividend Stocks

The Best Canadian ETFs $100 Can Buy on the TSX Today

If you're worried about not having enough to create a diversified portfolio, think again. These ETFs provide all that and…

Read more »

Doctor talking to a patient in the corridor of a hospital.
Dividend Stocks

Healthcare Sector: Top Picks for Canadian Investors in 2025

Health stocks offer some of the best growth opportunities out there, and these four stocks could be the best options.

Read more »